Literature DB >> 2548539

Surgical management of nasopharyngeal angiofibroma involving the cavernous sinus.

L G Close1, S D Schaefer, B E Mickey, S C Manning.   

Abstract

Involvement of the cavernous sinus by juvenile nasopharyngeal angiofibroma represents a therapeutic challenge. We present our experience over the past 5 years with the surgical management of six cases of juvenile nasopharyngeal angiofibroma involving this site. Three of six patients had involvement of the medial aspect of the cavernous sinus and tumor was removed using a midline extracranial approach. Of three remaining patients, two had invasion of the medial and inferior margin of the cavernous sinus and one represented a recurrent lesion. The tumor in these three cases was resected using a combined frontotemporal and lateral infratemporal fossa approach. An extracranial recurrence occurred in one patient, and the remaining five patients have had no evidence of recurrent disease 12 to 71 months following surgery. Morbidity has been limited to trismus, facial hypesthesia, and serous otitis media.

Entities:  

Mesh:

Year:  1989        PMID: 2548539     DOI: 10.1001/archotol.1989.01860330081022

Source DB:  PubMed          Journal:  Arch Otolaryngol Head Neck Surg        ISSN: 0886-4470


  4 in total

1.  Intracranial juvenile angiofibroma with intradural and cavernous sinus involvement.

Authors:  B M Lyons; P J Donald
Journal:  Skull Base Surg       Date:  1992

2.  Lateral orbital/anterior midfacial degloving approach for nasopharyngeal angiofibromas with cavernous sinus extension.

Authors:  J D Browne; A H Messner
Journal:  Skull Base Surg       Date:  1994

3.  Stridor: an unusual presentation of juvenile nasopharyngeal angiofibroma.

Authors:  Hitendra Prakash Singh; Sunil Kumar; Madhukar Vashishtha; Satya Prakash Agarwal
Journal:  BMJ Case Rep       Date:  2014-04-07

4.  Complete resolution of stage IIIB juvenile nasopharyngeal angiofibroma with radiation therapy.

Authors:  N B Shunyu; A Thakar; V Gupta
Journal:  Indian J Otolaryngol Head Neck Surg       Date:  2008-10-22
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.